Find policies, billing codes, payers, states, and providers
CPT 85018: Hemoglobin Measurement in Whole Blood
CPT code 85018 represents a laboratory assay that quantitatively measures hemoglobin concentration in a whole blood sample, a fundamental component of anemia evaluation and routine clinical assessment. Nationally, hemoglobin testing is a high-volume diagnostic service used across inpatient, outpatient, and primary care settings to inform diagnosis and management of anemia, fatigue, and screening for hematologic conditions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the test, commonly associated diagnostic indications, and how CPT code 85018 relates to other complete blood count and hematology codes. The publication highlights typical sites of service and the role of hemoglobin measurement in differential diagnosis and screening workflows.
This report also summarizes benchmark considerations and coding relationships to related hematology procedures, providing operational clarity for billing and clinical teams. Policy updates, payer coverage nuances, and comparative code context are presented to support accurate coding, claims submission, and interpretation within national payer frameworks.
Customize your policy alerts
Sign up for cpt 85018 policy alerts
Get alerted when payer policies referencing 85018 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 85018 describes a laboratory measurement of hemoglobin in a whole blood sample. Hemoglobin is the red-pigmented, iron-containing protein in red blood cells that binds and transports oxygen to body tissues. This service represents a quantitative hemoglobin assay performed by a laboratory analyst.
Service type: Laboratory diagnostic test (hematology)
Typical site of service: Clinical laboratory or hospital laboratory
National Reimbursement Benchmarks
For CPT 85018, BUCA’s average commercial rate sits at $17.10, representing a mid-market reference point across national commercial payers. Blue Cross Blue Shield displays a relatively narrow interquartile spread (P75 $17.00 minus P25 $9.90 = $7.10), and UnitedHealth Group also shows tight dispersion (P75 $2.80 minus P25 $1.40 = $1.40), indicating more consistent contracted rates. Cigna’s spread is modest (P75 $4.20 minus P25 $1.90 = $2.30), while Aetna exhibits the widest dispersion by far (P75 $7.10 minus P25 $2.00 = $5.10) when considering its very large maximum outlier.
Blue Cross Blue Shield and UnitedHealth Group therefore represent the tightest interquartile consistency among listed payers, with ranges of $7.10 and $1.40 respectively, while Aetna shows the broadest middle-range variability at $5.10. Cigna and BUCA fall between those extremes, with Cigna’s IQR at $2.30 and BUCA’s interquartile range at $5.30 (P75 $11.70 minus P25 $6.40 = $5.30), reflecting moderate dispersion around BUCA’s $17.10 average.